Study details
Enrolling now
Pelashield™ PainGuard™ vs Restrata® in HS Surgery
Rutgers, The State University of New Jersey
NCT IDNCT07316192ClinicalTrials.gov data as of Apr 2026
Target enrollment
10
Study length
about 10 months
Ages
18+
Locations
1 site in NJ
About this study
Researchers are testing if Pelashield™ PainGuard™, a new wound dressing, helps patients heal better after surgery for Hidradenitis Suppurativa (HS) compared to the current standard treatment, Restrata®. The trial will compare how quickly healthy tissue forms, when the wound is ready for graft placement, infection rates, and pain medication needs in both groups of patients.
Based on ClinicalTrials.gov records.
What participants do
- 1.Use Pelashield Painguard
Participation effort
Estimated from trial records. Details can vary by site.
Time + visits
Low15%
Logistics
Moderate50%
Logistics difficulty varies by site location and availability.